Abingworth’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-20,610
| Closed | -$344K | – | 18 |
|
|
2020
Q3 | $344K | Sell |
20,610
-33,002
| -62% | -$551K | 0.07% | 15 |
|
|
2020
Q2 | $3M | Sell |
53,612
-60,307
| -53% | -$3.38M | 0.84% | 11 |
|
|
2020
Q1 | $2.62M | Buy |
113,919
+60,306
| +112% | +$1.39M | 1.74% | 11 |
|
|
2019
Q4 | $879K | Buy |
53,613
+3,166
| +6% | +$51.9K | 0.42% | 12 |
|
|
2019
Q3 | $525K | Hold |
50,447
| – | – | 0.33% | 12 |
|
|
2019
Q2 | $851K | Hold |
50,447
| – | – | 0.33% | 12 |
|
|
2019
Q1 | $1.01M | Hold |
50,447
| – | – | 0.9% | 12 |
|
|
2018
Q4 | $4.58M | Hold |
50,447
| – | – | 4.16% | 8 |
|
|
2018
Q3 | $3.83M | Hold |
50,447
| – | – | 2.28% | 7 |
|
|
2018
Q2 | $4.84M | Hold |
50,447
| – | – | 2.77% | 6 |
|
|
2018
Q1 | $5.05M | Hold |
50,447
| – | – | 3.14% | 6 |
|
|
2017
Q4 | $3.73M | Hold |
50,447
| – | – | 2.7% | 7 |
|
|
2017
Q3 | $3.94M | Hold |
50,447
| – | – | 2.72% | 6 |
|
|
2017
Q2 | $3.03M | Hold |
50,447
| – | – | 2.41% | 7 |
|
|
2017
Q1 | $3.43M | Hold |
50,447
| – | – | 2.56% | 7 |
|
|
2016
Q4 | $3.63M | Hold |
50,447
| – | – | 3.04% | 6 |
|
|
2016
Q3 | $18.4M | Hold |
50,447
| – | – | 17.62% | 2 |
|
|
2016
Q2 | $16.3M | Hold |
50,447
| – | – | 17.03% | 2 |
|
|
2016
Q1 | $15.6M | Hold |
50,447
| – | – | 14.46% | 3 |
|
|
2015
Q4 | $31.3M | Hold |
50,447
| – | – | 18.88% | 2 |
|
|
2015
Q3 | $27.4M | Hold |
50,447
| – | – | 16.02% | 2 |
|
|
2015
Q2 | $36M | Hold |
50,447
| – | – | 16.36% | 2 |
|
|
2015
Q1 | $22.7M | Hold |
50,447
| – | – | 9.64% | 5 |
|
|
2014
Q4 | $20.3M | Buy |
+50,447
| New | +$20.3M | 5.78% | 7 |
|